JNJ Short Volume
Johnson & Johnson (JNJ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $613.02B, listed on NYSE, employing roughly 141,700 people, carrying a beta of 0.26 to the broader market. Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. Led by Joaquin Duato, public since 1962-01-02.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-30
- Short Volume
- 1.1M
- Total Volume
- 2.1M
- Short %
- 54.37%
- 30-Day Avg Short %
- 46.41%
Showing 30 days of FINRA short volume data for Johnson & Johnson.
Learn how short volume is reported and how to read the data →
Frequently asked JNJ short volume questions
- What is the daily JNJ short volume?
- As of Jun 30, 2026, Johnson & Johnson (JNJ) short volume is 1.1M shares against 2.1M total reported volume, or 54.37% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is JNJ short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does JNJ short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.